United States · FDA National Drug Code directory
Iclusig
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63020-536_2034440d-14ab-475e-affc-5261ac3683a6
- Product NDC
- 63020-536
- Form
- TABLET, FILM COATED
- Composition / generic term
- ponatinib hydrochloride
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210111
- Source listing expiry
- 20271231
Source-listed ingredients
- PONATINIB HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (63020-536-30) · 63020-536-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →